Announcements and Notices - [Terms of Reference of the Nomination Committee]

Brii Biosciences operates as a biotechnology company. The Company discovers and develops therapeutics and medicines for the treatment of diseases. Brii Biosciences serves customers in the United States and China.

Terms Of Reference Of The Nomination Committee

Announcements and Notices - [Other - Business Update]

Voluntary Announcement
Presents Late-Breaking Data From Ongoing Phase 2 Ensure Study At Aasld 2025

Voluntary Announcement
Publication Of Phase 2 Ensure Study Results In Nature Medicine

Announcements and Notices - [Share Scheme]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Brii Biosciences (2137 HK)

Terms Of Reference Of The Nomination Committee

Voluntary Announcement Presents Late-Breaking Data From Ongoing Phase 2 Ensure Study At Aasld 2025

Voluntary Announcement Publication Of Phase 2 Ensure Study Results In Nature Medicine

Grant Of Share Options

Grant Of Share Options And Restricted Share Units

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)